Literature DB >> 12449428

The structure and function of novel proteins of Bacillus anthracis and other spore-forming bacteria: development of novel prophylactic and therapeutic agents.

Mark J Jedrzejas1.   

Abstract

The overall goal of this review is to summarize the current body of knowledge about the structure and function of major proteins of Bacillus anthracis and/or similar spore-forming organisms. B. anthracis is a key spore-forming biological threat agent, as well as human and animal Gram-positive bacterial pathogen. The structural information described here is limited to approximately the last 5 years. This information is then related to the role of the selected proteins in pathogenesis and in the possible development of novel vaccine and/or other antimicrobial agents against spore-forming organisms, including anthrax, a disease caused by B. anthracis. Among spore-forming bacteria, Bacillus and Clostridium species are the predominant spore-forming bacilli that cause serious diseases. The biochemical properties and mechanism of catalysis of the novel spore germination protease that degrades small, acid-soluble proteins protecting DNA against damage, a cofactor independent phosphoglycerate mutase, NAD+ synthetase, and the three know B. anthracis toxins, protective antigen, lethal factor, and edema factor are described. The studies described in this work review and unify selected information critical for the prevention of microbial diseases such as anthrax. A strategy for the structure-guided development of new prophylactic and therapeutic agents is discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12449428     DOI: 10.1080/10409230290771537

Source DB:  PubMed          Journal:  Crit Rev Biochem Mol Biol        ISSN: 1040-9238            Impact factor:   8.250


  9 in total

1.  Inhibition of the adenylyl cyclase toxin, edema factor, from Bacillus anthracis by a series of 18 mono- and bis-(M)ANT-substituted nucleoside 5'-triphosphates.

Authors:  Hesham Taha; Stefan Dove; Jens Geduhn; Burkhard König; Yuequan Shen; Wei-Jen Tang; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-09-24       Impact factor: 3.000

2.  Distinct interactions of 2'- and 3'-O-(N-methyl)anthraniloyl-isomers of ATP and GTP with the adenylyl cyclase toxin of Bacillus anthracis, edema factor.

Authors:  Srividya Suryanarayana; Jenna L Wang; Mark Richter; Yuequan Shen; Wei-Jen Tang; Gerald H Lushington; Roland Seifert
Journal:  Biochem Pharmacol       Date:  2009-08-01       Impact factor: 5.858

3.  Molecular analysis of the interaction of anthrax adenylyl cyclase toxin, edema factor, with 2'(3')-O-(N-(methyl)anthraniloyl)-substituted purine and pyrimidine nucleotides.

Authors:  Hesham M Taha; Jennifer Schmidt; Martin Göttle; Srividya Suryanarayana; Yuequan Shen; Wei-Jen Tang; Andreas Gille; Jens Geduhn; Burkhard König; Stefan Dove; Roland Seifert
Journal:  Mol Pharmacol       Date:  2008-12-04       Impact factor: 4.436

4.  Construction and Analysis of Two Genome-Scale Deletion Libraries for Bacillus subtilis.

Authors:  Byoung-Mo Koo; George Kritikos; Jeremiah D Farelli; Horia Todor; Kenneth Tong; Harvey Kimsey; Ilan Wapinski; Marco Galardini; Angelo Cabal; Jason M Peters; Anna-Barbara Hachmann; David Z Rudner; Karen N Allen; Athanasios Typas; Carol A Gross
Journal:  Cell Syst       Date:  2017-02-08       Impact factor: 10.304

5.  Structure and molecular mechanism of Bacillus anthracis cofactor-independent phosphoglycerate mutase: a crucial enzyme for spores and growing cells of Bacillus species.

Authors:  Masatoshi Nukui; Luciane V Mello; James E Littlejohn; Barbara Setlow; Peter Setlow; Kijeong Kim; Terrance Leighton; Mark J Jedrzejas
Journal:  Biophys J       Date:  2006-11-03       Impact factor: 4.033

6.  Artificially sporulated Escherichia coli cells as a robust cell factory for interfacial biocatalysis.

Authors:  Zhiyong Sun; René Hübner; Jian Li; Changzhu Wu
Journal:  Nat Commun       Date:  2022-06-06       Impact factor: 17.694

7.  Nicotinamide mononucleotide synthetase is the key enzyme for an alternative route of NAD biosynthesis in Francisella tularensis.

Authors:  Leonardo Sorci; Dariusz Martynowski; Dmitry A Rodionov; Yvonne Eyobo; Xhavit Zogaj; Karl E Klose; Evgeni V Nikolaev; Giulio Magni; Hong Zhang; Andrei L Osterman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-09       Impact factor: 11.205

8.  Virtual screening to identify lead inhibitors for bacterial NAD synthetase (NADs).

Authors:  Whitney Beysselance Moro; Zhengrong Yang; Tasha A Kane; Christie G Brouillette; Wayne J Brouillette
Journal:  Bioorg Med Chem Lett       Date:  2009-02-12       Impact factor: 2.823

9.  Different ways to transport ammonia in human and Mycobacterium tuberculosis NAD+ synthetases.

Authors:  Watchalee Chuenchor; Tzanko I Doukov; Kai-Ti Chang; Melissa Resto; Chang-Soo Yun; Barbara Gerratana
Journal:  Nat Commun       Date:  2020-01-07       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.